Fate Therapeutics (FATE) Prepaid Assets (2012 - 2026)
Fate Therapeutics (FATE) reported Prepaid Assets of $4.0 million for Q1 2026, down 25.73% on a YoY basis from $5.4 million in Q1 2025, and down 3.17% quarter-over-quarter from $4.1 million in Q4 2025.
Fate Therapeutics (FATE) Prepaid Assets (2012 - 2026) Analysis & Trends
Fate Therapeutics has reported Prepaid Assets for 15 years, with the latest figure at $4.0 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets fell 25.73% year-over-year to $4.0 million; the trailing twelve-month figure through Mar 2026 stood at $4.0 million (down 25.73% YoY), and the FY2025 full-year result was $4.1 million, down 55.59% from the prior year.
- Prepaid Assets for Q1 2026 stood at $4.0 million, down from $4.1 million in the prior quarter.
- The five-year high for Prepaid Assets was $27.4 million in Q4 2022, with the low at $4.0 million in Q1 2026.
- Historically, Prepaid Assets has averaged $11.6 million across 5 years, with a median of $11.4 million in 2023.
- Annual changes were most pronounced in 2022 — Prepaid Assets surged 210.07% — and 2025, when it tumbled 55.59%.
- Fate Therapeutics' Prepaid Assets stood at $27.4 million in 2022, then slumped by 46.87% to $14.5 million in 2023, then sank by 36.02% to $9.3 million in 2024, then plunged by 55.59% to $4.1 million in 2025, then retreated by 3.17% to $4.0 million in 2026.
- The last three Prepaid Assets figures came in at $4.0 million (Q1 2026), $4.1 million (Q4 2025), and $5.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Fate Therapeutics | 250.86 Mn | 250.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.00 Mn |
| Dec 31, 2025 | 4.13 Mn |
| Sep 30, 2025 | 5.15 Mn |
| Jun 30, 2025 | 6.17 Mn |
| Mar 31, 2025 | 5.39 Mn |
| Dec 31, 2024 | 9.30 Mn |
| Sep 30, 2024 | 9.24 Mn |
| Jun 30, 2024 | 13.46 Mn |
| Mar 31, 2024 | 9.97 Mn |
| Dec 31, 2023 | 14.54 Mn |
| Sep 30, 2023 | 12.90 Mn |
| Jun 30, 2023 | 11.41 Mn |
| Mar 31, 2023 | 15.49 Mn |
| Dec 31, 2022 | 27.37 Mn |
| Sep 30, 2022 | 19.97 Mn |
| Jun 30, 2022 | 17.18 Mn |
| Mar 31, 2022 | 11.45 Mn |
| Dec 31, 2021 | 8.83 Mn |
| Sep 30, 2021 | 7.70 Mn |
| Jun 30, 2021 | 7.37 Mn |